- Home
- ANGH vs HOOK Comparison
ANGH vs HOOK Comparison
Compare ANGH & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- HOOK
- Stock Information
- Founded
- ANGH 2012
- HOOK 2011
- Country
- ANGH United Arab Emirates
- HOOK United States
- Employees
- ANGH N/A
- HOOK N/A
- Industry
- ANGH Telecommunications Equipment
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- ANGH Consumer Discretionary
- HOOK Health Care
- Exchange
- ANGH Nasdaq
- HOOK Nasdaq
- Market Cap
- ANGH 64.7M
- HOOK 61.8M
- IPO Year
- ANGH N/A
- HOOK 2019
- Fundamental
- Price
- ANGH $0.89
- HOOK $4.74
- Analyst Decision
- ANGH
- HOOK Strong Buy
- Analyst Count
- ANGH 0
- HOOK 4
- Target Price
- ANGH N/A
- HOOK $39.25
- AVG Volume (30 Days)
- ANGH 9.0K
- HOOK 22.2K
- Earning Date
- ANGH 04-29-2024
- HOOK 08-08-2024
- Dividend Yield
- ANGH N/A
- HOOK N/A
- EPS Growth
- ANGH N/A
- HOOK N/A
- EPS
- ANGH N/A
- HOOK N/A
- Revenue
- ANGH $41,380,440.00
- HOOK $52,163,000.00
- Revenue This Year
- ANGH N/A
- HOOK $165.17
- Revenue Next Year
- ANGH N/A
- HOOK N/A
- P/E Ratio
- ANGH N/A
- HOOK N/A
- Revenue Growth
- ANGH N/A
- HOOK 227.80
- 52 Week Low
- ANGH $0.63
- HOOK $4.10
- 52 Week High
- ANGH $3.49
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- ANGH 49.62
- HOOK 38.95
- Support Level
- ANGH $0.83
- HOOK $5.08
- Resistance Level
- ANGH $0.95
- HOOK $5.23
- Average True Range (ATR)
- ANGH 0.06
- HOOK 0.31
- MACD
- ANGH 0.01
- HOOK 0.02
- Stochastic Oscillator
- ANGH 54.76
- HOOK 13.21
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with the catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner and is continuously licensing new content.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.